Kramer MS - Search Results

1

Clinical biostatistics. LIV. The biostatistics of concordance.

Kramer MS, Feinstein AR. Kramer MS, et al. Clin Pharmacol Ther. 1981 Jan;29(1):111-23. doi: 10.1038/clpt.1981.18. Clin Pharmacol Ther. 1981. PMID: 7460469 No abstract available.

2

Clinical biostatistics. LII. A primer on quantitative indexes of association.

Feinstein AR, Kramer MS. Feinstein AR, et al. Among authors: kramer ms. Clin Pharmacol Ther. 1980 Jul;28(1):130-45. doi: 10.1038/clpt.1980.141. Clin Pharmacol Ther. 1980. PMID: 7389250 No abstract available.

3

Clinical biostatistics. LIII. The architecture of observer/method variability and other types of process research.

Feinstein AR, Kramer MS. Feinstein AR, et al. Among authors: kramer ms. Clin Pharmacol Ther. 1980 Oct;28(4):551-63. doi: 10.1038/clpt.1980.202. Clin Pharmacol Ther. 1980. PMID: 7408416 No abstract available.

4

Operational criteria for adverse drug reactions in evaluating suspected toxicity of a popular scabicide.

Kramer MS, Hutchinson TA, Rudnick SA, Leventhal JM, Feinstein AR. Kramer MS, et al. Clin Pharmacol Ther. 1980 Feb;27(2):149-55. doi: 10.1038/clpt.1980.23. Clin Pharmacol Ther. 1980. PMID: 6153304

5

An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use.

Kramer MS, Leventhal JM, Hutchinson TA, Feinstein AR. Kramer MS, et al. JAMA. 1979 Aug 17;242(7):623-32. JAMA. 1979. PMID: 449002

6

An algorithm for the operational assessment of adverse drug reactions. III. Results of tests among clinicians.

Leventhal JM, Hutchinson TA, Kramer MS, Feinstein AR. Leventhal JM, et al. Among authors: kramer ms. JAMA. 1979 Nov 2;242(18):1991-4. JAMA. 1979. PMID: 480646

7

An algorithm for the operational assessment of adverse drug reactions. II. Demonstration of reproducibility and validity.

Hutchinson TA, Leventhal JM, Kramer MS, Karch FE, Lipman AG, Feinstein AR. Hutchinson TA, et al. Among authors: kramer ms. JAMA. 1979 Aug 17;242(7):633-8. JAMA. 1979. PMID: 449003

8

Reasons for disagreement in the standardized assessment of suspected adverse drug reactions.

Hutchinson TA, Flegel KM, HoPingKong H, Bloom WS, Kramer MS, Trummer EG. Hutchinson TA, et al. Among authors: kramer ms. Clin Pharmacol Ther. 1983 Oct;34(4):421-6. doi: 10.1038/clpt.1983.192. Clin Pharmacol Ther. 1983. PMID: 6617062 No abstract available.

9

Directionality, timing, and sample selection in epidemiologic research design.

Kramer MS, Boivin JF. Kramer MS, et al. J Clin Epidemiol. 1989;42(9):827-8. doi: 10.1016/0895-4356(89)90094-2. J Clin Epidemiol. 1989. PMID: 2778463 No abstract available.

10

The importance of directionality in epidemiologic research design.

Kramer MS, Boivin JF. Kramer MS, et al. J Clin Epidemiol. 1988;41(8):717-8. doi: 10.1016/0895-4356(88)90156-4. J Clin Epidemiol. 1988. PMID: 3418360 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results